Literature DB >> 6170028

Origins of spinal noradrenergic pathways demonstrated by retrograde transport of antibody to dopamine-beta-hydroxylase.

K N Westlund, R M Bowker, M G Ziegler, J D Coulter.   

Abstract

Retrograde transport of antibody to dopamine-beta-hydroxylase (DBH) was used to locate the cells of origin of descending noradrenergic (and possibly adrenergic) pathways to the spinal cord. Following injections of DBH antibody into various spinal cord levels, cell bodies were immunocytochemically localized in brainstem nuclei known to contain noradrenergic neurons. These cell groups included the nucleus locus coeruleus, the nucleus subcoeruleus, the medial and lateral parabrachial nuclei, the Kölliker-Fuse nucleus, and the region dorsal and lateral to the superior olivary nucleus. Caudally, none of the noradrenergic cell groups of the medulla contained retrogradely labeled neurons. These findings indicate that the sources of spinal cord noradrenergic input are derived exclusively from the cells of the pons.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170028     DOI: 10.1016/0304-3940(81)90399-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  A delta afferent fiber stimulation activates descending noradrenergic system from the locus coeruleus.

Authors:  T Hitoto; M Tsuruoka; Y Hiruma; Y Matsui
Journal:  Neurochem Res       Date:  1998-12       Impact factor: 3.996

2.  Noradrenergic innervation of the rat spinal cord caudal to a complete spinal cord transection: effects of olfactory ensheathing glia.

Authors:  Aya Takeoka; Marc D Kubasak; Hui Zhong; Jennifer Kaplan; Roland R Roy; Patricia E Phelps
Journal:  Exp Neurol       Date:  2009-12-16       Impact factor: 5.330

3.  Catecholamine metabolism in the vas deferens and the adrenal gland with special reference to the central catecholamine-depleted state.

Authors:  T Yamaguchi; T Nakada
Journal:  Experientia       Date:  1992-07-15

4.  Spinal projections of the A5, A6 (locus coeruleus), and A7 noradrenergic cell groups in rats.

Authors:  Eveline Bruinstroop; Georgina Cano; Veronique G J M Vanderhorst; Judney C Cavalcante; Jena Wirth; Miguel Sena-Esteves; Clifford B Saper
Journal:  J Comp Neurol       Date:  2012-06-15       Impact factor: 3.215

5.  Modulation of experimental arthritis by vagal sensory and central brain stimulation.

Authors:  Gabriel Shimizu Bassi; Daniel Penteado Martins Dias; Marcelo Franchin; Jhimmy Talbot; Daniel Gustavo Reis; Gustavo Batista Menezes; Jaci Airton Castania; Norberto Garcia-Cairasco; Leonardo Barbosa Moraes Resstel; Helio Cesar Salgado; Fernando Queiróz Cunha; Thiago Mattar Cunha; Luis Ulloa; Alexandre Kanashiro
Journal:  Brain Behav Immun       Date:  2017-04-06       Impact factor: 7.217

6.  The posterior hypothalamus exerts opposing effects on nociception via the A7 catecholamine cell group in rats.

Authors:  Y Jeong; J R Moes; M Wagner; J E Holden
Journal:  Neuroscience       Date:  2012-10-02       Impact factor: 3.590

7.  GABA-A receptor activity in the noradrenergic locus coeruleus drives trigeminal neuropathic pain in the rat; contribution of NAα1 receptors in the medial prefrontal cortex.

Authors:  R Kaushal; B K Taylor; A B Jamal; L Zhang; F Ma; R Donahue; K N Westlund
Journal:  Neuroscience       Date:  2016-08-09       Impact factor: 3.590

8.  Projections from the rat cuneiform nucleus to the A7, A6 (locus coeruleus), and A5 pontine noradrenergic cell groups.

Authors:  Dusica Bajic; Herbert K Proudfit
Journal:  J Chem Neuroanat       Date:  2013-03-20       Impact factor: 3.052

9.  Bulbar catecholaminergic neurons projecting to the thoracic spinal cord of the chicken. Evans Blue labeling study in combination with catecholamine histofluorescence.

Authors:  H Chikazawa; T Fujioka; T Watanabe
Journal:  Anat Embryol (Berl)       Date:  1983

10.  Descending projections from the caudal medulla oblongata to the superficial or deep dorsal horn of the rat spinal cord.

Authors:  I Tavares; D Lima
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.